Navigating complications of disease-modifying anti-rheumatic drugs at the 'front door'
Singh, Ruchir Croft, Adam P
Singh, Ruchir
Croft, Adam P
Abstract
Disease-modifying anti-rheumatic drugs (DMARDs) have revolutionised the treatment landscape in rheumatology, reducing both disease severity and the risk of systemic co-morbidities. These immunomodulatory drugs have been re-purposed for use in other chronic inflammatory diseases, conferring further advantages. However, DMARDs can be associated with adverse events that have implications for the management of common symptoms and conditions that present to medical services at the 'front door'.
MIDER Authors
Date
2025-08-20
Type
Review
Subject
Rheumatology, Inflammation, Drug-related side effects and adverse reactions, Immunosuppressive agents, Infection
Collections
Citation
Singh R, Croft AP. Navigating complications of disease-modifying anti-rheumatic drugs at the 'front door'. Clin Med (Lond). 2025 Aug 20:100504. doi: 10.1016/j.clinme.2025.100504.
Journal / Source Title
Clinical medicine
DOI
10.1016/j.clinme.2025.100504
PMID
40846120
Publisher
Elsevier Ltd
Publisher’s URL
https://pmc.ncbi.nlm.nih.gov/journals/?term=101092853
https://www.sciencedirect.com/journal/clinical-medicine
https://www.sciencedirect.com/journal/clinical-medicine